Under the leadership of Steven A. Curley, M.D., faculty surgeons, armed with broad surgical oncology expertise will continue to leverage ground breaking translational research to effectively address the clinical needs of their patients.
Surgery residents rotate on the surgical oncology service with division faculty, gaining clinical and operative experience in caring for patients with hepatobiliary, pancreatic, colorectal, other gastrointestinal, breast, sarcoma, melanoma, and neuroendocrine malignancies. The role and timing of surgical therapies is emphasized because modern surgical oncology requires an understanding of the use of multiple modalities including chemotherapy, cellular and biologic therapies, and radiation therapy. Teaching occurs in the operating theaters, at the bedside, and in the clinic where residents participate in the real-time multidisciplinary treatment planning. Residents are exposed to the complex issues involved in managing patients during neoadjuvant or adjuvant therapies and to recognize quality of life problems that arise during treatment and in long-term survivorship.
The Division of Surgical Oncology specializes in the treatment of soft tissue, hepatobiliary, pancreatic, colorectal, other gastrointestinal tract , breast, skin, and endocrine cancers, integrating advanced minimally invasive and standard surgical techniques into surgical practice. Cancer patients are usually treated by a multidisciplinary care team and each patient is treated with an individualized, personal approach. Surgical treatments are state-of-the-art and the importance of optimal patient outcomes are always an emphasis. Our surgeons are trained in advanced oncologic surgical techniques and we know the potentially curative role of surgery as the leading edge of allied therapies, and also understand when to consider and perform palliative surgical approaches to improve patients’ quality of life.
Developing novel approaches for cancer gene therapy, immunotherapy, non-invasive radiofrequency field therapy to enhance tumor blood flow and produce modulated tumor-specific hyperthermia, use of nanotechnology to improve cancer detection, and robotic surgery are among the division's several basic science research pursuits. Areas of recent translational research focus have included the compilation of tissue-based databases that help track and understand patient outcomes in pancreatic, hepatobiliary, and colorectal cancers. Additionally, our clinical research initiatives include detecting genetic profiles and differences in circulating tumor cells in patients with primary and metastatic colorectal cancer, developing hyperthermic treatment programs for patients with peritoneal-based malignancies, and expanding neoadjuvant treatments in patients with pancreatic, hepatobiliary, colorectal, and breast malignancies.